In part 5 of this Exclusive Interview, Dr. Jim McDermott explains DapaCare, the umbrella term that covers AstraZeneca's clinical program with Farxiga (dapagliflozin) in a conversation with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA.
Read More »Monthly Archives: February 2018
Jim McDermott Part 6, SGLT2 Cardiovascular Trials
In part 6, the conclusion of this Exclusive Interview, Dr. Jim McDermott explains SGLT2 cardiovascular trials, including the DECLARE trial that will complete in 2018, in a conversation with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA.
Read More »Feb. 20, 2018
There have been a lot of diseases associated with diabetes, and it is often said that, although it is never on the death certificate, diabetes is the biggest killer. We often can think of some of the common ones, like heart failure, stroke, and kidney failure. And other conditions that …
Read More »To Give Your Patients Hope, Listen Well to The Stories They Tell Themselves
I recently met a patient whose life is alternative medicine. Not complementary medicine but alternative medicine. A young woman in her early 30’s who was diagnosed with type 1 diabetes 10 years ago. Besides having an A1C of 10.5%, I could tell she was struggling. Her career is in alternative medicine. For years she has been looking for a way to stop taking insulin. She is looking for the cure, but as with many, has difficulty believing it’s not here yet. She has had diabetes education, but because she hasn’t really met the hcp she can relate to or who has given her the answer she wants to hear, she’s not really put things together yet.
Read More »Framework for Understanding DM Part 9
In this week's Homerun Slides, practical implementation of the common origins of diabetes and its complications construct.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #113: Diabetes and Sleep Apnea Part 3
OSA pathophysiology: OSA is a very complex disorder, and although obesity and fat deposition around the neck plays an important role, there are many other important players that contribute to the development of this condition. The human upper airway is a unique multipurpose structure involved in performing a variety of tasks such as speech, swallowing, and the passage of air for breathing. The airway, therefore, is composed of numerous muscles and soft tissue but lacks rigid or bony support. Most notably, it contains a collapsible portion that extends from the hard palate to the larynx, which allows the upper airway to change shape and momentarily for speech and swallowing during wakefulness; but this feature also provides the opportunity for collapse at inopportune times such as during sleep.
Read More »Feb. 17, 2018
When I was working with endocrinologists they would often place their type one patients on metformin. I would share this with primary prescribers, and they too had good results using a type 2 drug for insulin dependent patients. We now have more choices than ever for patients and it only …
Read More »SGLT2 Inhibitors in Treatment of Type 1
Meta-analysis explores safety and efficacy of sodium-glucose co-transporter 2 inhibitors in patients with type 1 diabetes.
Read More »Study Explores Breast Cancer Outcomes and Treatment in Women Who Have Diabetes
Females with breast cancer and diabetes have poorer prognosis than those with breast cancer without diabetes, but why?
Read More »ESRD in Type 1 Diabetes: What Has Changed?
Although the risk of end-stage renal disease remains high for individuals with type 1 diabetes, lifetime likelihood of ESRD has substantially decreased over the last 50 years.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.